ChartRow logo
NVO
Novo Nordisk A/SStock · Health CareMSCI EAFE 0.6% · MSCI World 0.2% · MSCI ACWI 0.1% · US Stock Market 0.0000%
$43.24+0.12%
as of market close, Sep 18, 2026
☀ Pre $40.70 -5.87%
PeersMRNALLYUNHJNJMRKTMO

NVO — Novo Nordisk A/S price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in NVO be worth today? →
NVO returns: By year · By month · By week · Trailing

Key stats

Price data

Price
$43.24
Change YTD
-15.02%
Next earnings
Nov 4, 2026
Market cap
192.2B
Enterprise value
207.1B
Shares outstanding
4.4B
52W low
$35.12
52W high
$64.16
From 52W high
-32.61%
From 52W low
+23.12%
52W range
28%
Beta
0.74

Volume

Rel volume
0.98×
30D volume
10.5M
30D $ vol
480.8M

Fundamentals

Sales (ttm)
46.6B
Sales/share
$10.50
EPS (ttm)
$3.48
FCF (ttm)
18B
FCF/share
$4.05
Book value/share
$6.87
Net margin
33.14%
ROE
50.62%
ROA
18.09%
Debt / equity
0.57×
Current ratio
0.80

Growth (CAGR, ttm) · 10Y

Sales
+10.85%+23.09%+19.16%n/a
Net income
+5.65%+25.36%+19.13%n/a
Shares
+0.07%-0.42%-1.11%n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
+6.00%+26.25%+20.34%n/a
Sales/share
+10.78%+23.60%+20.51%n/a
Book value/share
+52.70%+37.05%+25.46%n/a
Dividend/share
+6.90%+26.31%+20.47%n/a
Price
-30.11%-22.61%-3.13%+6.49%
Total return
-26.61%-20.34%-0.94%+8.90%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
12.4×
P/OI (ttm)
10.0×
Fwd P/E
12.3×
P/S (ttm)
4.1×
P/B (mrq)
6.3×
P/FCF (ttm)
10.7×
EV/EBITDA (fy)
9.6×
EV/Sales (ttm)
4.4×
FCF yield (ttm)
9.36%
Dividend yield (fwd)
4.08%
Dividend/share (fwd)
$1.77
Buyback yield (realized, 1y)
-0.07%
Shareholder yield (realized, 1y)
1.98%
Buyback yield (cash, ttm)
0.11%
Shareholder yield (cash, ttm)
4.17%

Vs own 10Y history

P/E
4th
P/OI
4th
P/S
4th
P/B
4th

Bar = where today’s multiple sits in NVO’s own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return · as of 2026-09-18

1D
+0.12%
5D
+0.39%
1M
-5.40%
3M
+0.12%
YTD
-15.02%
1Y
-30.09%
5Y
-14.72%

Financial statements

Open full NVO financials →
Loading financial statements…
TickerName1M1D
NVSNovartis AG-9.18%-0.39%
SNYSanofi ADS-5.54%-1.53%
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)-1.82%-1.65%
ARGXargenx SE American Depositary Shares-0.27%-0.55%
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)+4.76%-0.73%
NTRANatera Inc.+18.51%+0.84%
TEVATeva Pharmaceutical Industries Limited American Depositary Shares+6.56%-0.54%
RVMDRevolution Medicines Inc.-11.60%-3.04%

Novo Nordisk A/S (NVO) trades at $43.24 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes NVO’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full NVO financial statements →